Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Impact Of Ejection Fraction On The Therapeutic Effect Of Omecamtiv Mecarbil In Patients With Heart Failure And Reduced Ejection Fraction: A Secondary Analysis From GALACTIC-HF May 15, 2021 2021 | ACC | Cardiology | Slides | Video Tags: 2021, ACC, Cardiology, slides, video Loading… Taking too long? Reload document | Open in new tab Download Disclosures: TBD Article Navigation Dr. Douglas Mann and Dr. C. Michael Gibson Discuss: Sacubitril/Valsartan (LCZ696) In Patients With Advanced Heart Failure And Reduced Ejection Fraction: Results Of The LIFE Trial Dr. Mikhail Kosiborod and Dr. C. Michael Gibson Discuss: Effects Of Dapagliflozin On Prevention Of Major Clinical Events And Recovery In Patients With Respiratory Failure Due To COVID-19 – Main Results From The DARE-19 Randomized Trial
Reload document 
Open in new tab